-
The risks for illness acquired during travel are greater in immunocompromised travelers.
-
Faced with limited data about acute mountain sickness in children traveling rapidly to high altitude, Swiss researchers studied symptoms in 48 children (ages 10-17, mean age 13) who traveled 2 ½ hours from low altitude (568 meters) to 3450 meters (approximately 11,200 feet).
-
Influenza activity has been relatively low thus far in the 2008-2009 season in the United States.
-
Diffuse lepromatous leprosy (DLL) is an especially virulent form of multibacillary disease, occasionally seen in patients from Central and South America and Southeast Asia. Lucio's phenomena is a highly anergic and more severe form of DLL, resulting in extensive skin and subcutaneous involvement, with an abundance of organisms infiltrating tissues.
-
At the 57th Annual Meeting of the American Society of Tropical Medicine and Hygiene in New Orleans, Louisiana, held from December 7-11, 2008, the Centers for Disease Control and Prevention presented malaria and travel vaccine updates.
-
In this issue: The JUPITER trial causes a stir; ACP practice guideline for antidepressant use; testosterone for low libido; continued shortage of Hib vaccine; FDA Actions.
-
Many physicians have followed the historical practice of ordering blood cultures to be drawn as close as possible to the time of the peak of the febrile episode (fever spike).
-
New data and consensus discussions provide updated guidance about the use of hepatitis A vaccine for young children, in US residents, and in individuals who are traveling very soon after their pretravel consultations.
-
An excellent update on rabies was provided by Charles E. Rupprecht, the Rabies Section Chief of the CDC, during the Symposium, Control of Zoonoses: A Veterinary Perspective at the recent 51st annual ASTMH meeting in Denver, Colo.
-
FDA Approves Generic Version of AstraZenecas Prilosec; Pegasys
Approved To Treat Hepatitis C; HRT Reduces Alzheimers Risk, Study
Says; Heparin Plus Alteplase More Effective; Digoxin Effects Differ By
Sex; McClellan Named FDA Commissioner; FDA Actions